Next-Generation Vascular Occlusion System with Advanced Materials and Real-Time Monitoring

Publication ID: 24-11857737_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Vascular Occlusion System with Advanced Materials and Real-Time Monitoring,” Published Technical Disclosure No. 24-11857737_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857737_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,737.

Summary of the Inventive Concept

A revolutionary vascular occlusion system that integrates cutting-edge materials, micro-robotic navigation, and artificial intelligence-driven real-time monitoring to optimize perfusion, minimize ischemia, and reduce trauma to vascular tissue.

Background and Problem Solved

The original patent's low-profile occlusion balloon catheter, while effective, has limitations in terms of precision, real-time monitoring, and adaptability. The new inventive concept addresses these limitations by introducing advanced materials, micro-robotic navigation, and artificial intelligence-driven real-time monitoring to provide a more effective, efficient, and personalized vascular occlusion system.

Detailed Description of the Inventive Concept

The next-generation vascular occlusion system comprises a bio-absorbable occlusion balloon, a micro-robotic navigation module, and a real-time monitoring system. The bio-absorbable occlusion balloon is designed to dissolve in situ after a predetermined period, eliminating the need for balloon retrieval and minimizing vascular trauma. The micro-robotic navigation module enables precise catheter placement and real-time perfusion monitoring, while the artificial intelligence-driven real-time monitoring system optimizes perfusion and minimizes ischemia. Additionally, the system can be configured with nanotechnology-enhanced occlusion balloons for targeted delivery of therapeutic agents, shape-memory alloy-based occlusion devices for remote actuation and adjustment, and modular, multi-lumen occlusion catheter systems for real-time monitoring of vascular parameters.

Novelty and Inventive Step

The new inventive concept's integration of advanced materials, micro-robotic navigation, and artificial intelligence-driven real-time monitoring represents a significant departure from the original patent's low-profile occlusion balloon catheter. The use of bio-absorbable occlusion balloons, micro-robotic navigation modules, and real-time monitoring systems enables a more precise, efficient, and adaptive vascular occlusion system that minimizes ischemia and trauma to vascular tissue.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different advanced materials, such as nanomaterials or metamaterials, for the occlusion balloon. Additionally, the micro-robotic navigation module could be replaced with other navigation systems, such as electromagnetic or ultrasound-based systems. The real-time monitoring system could also be configured to integrate with other medical devices, such as ECG or blood pressure monitors, to provide a more comprehensive view of the patient's vascular health.

Potential Commercial Applications and Market

The next-generation vascular occlusion system has significant commercial potential in the medical device industry, particularly in the fields of cardiology, vascular surgery, and interventional radiology. The system's ability to optimize perfusion, minimize ischemia, and reduce trauma to vascular tissue makes it an attractive solution for hospitals, clinics, and medical research institutions. The market for vascular occlusion systems is expected to grow significantly in the coming years, driven by an increasing demand for minimally invasive medical procedures and the need for more effective and efficient vascular occlusion systems.

CPC Classifications

SectionClassGroup
A A61 A61M25/0068
A A61 A61B17/12036
A A61 A61M25/008
A A61 A61M25/0074
A A61 A61M25/1002
A A61 A61M25/104
A A61 A61M25/1006
A A61 A61M25/10182
A A61 A61B17/12045
A A61 A61B17/12109
A A61 A61B2017/00017
A A61 A61M25/007
A A61 A61M2025/0002
A A61 A61M2025/1052
A A61 A61M2025/1059
A A61 A61M2025/1081
A A61 A61M2025/1084
A A61 A61M2025/1086
A A61 A61M2025/1093

Field of Art

Medical device engineering, specifically interventional cardiology and vascular catheter technologies, involving advanced materials, micro-robotic systems, and minimally invasive medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in catheter design, vascular intervention techniques, advanced materials science, and medical device development, typically holding a PhD or equivalent professional experience in medical device engineering

Obviousness Rationale

A PHOSITA would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's occlusion balloon catheter technology, utilizing known engineering techniques and emerging medical technologies to enhance vascular intervention capabilities. The integration of bio-absorbable materials, micro-robotic navigation, and real-time monitoring represents incremental improvements that would be obvious to a skilled practitioner seeking to optimize vascular occlusion procedures. The fundamental principles of catheter design and vascular intervention established in the source patent provide a clear technological foundation for these advanced variations.

Obvious Combinations & Variations

Source Patent Element
Asymmetrical occlusion balloon design with conical and spherical portions
PTD Variation
Bio-absorbable occlusion balloon with shape-memory alloy integration for dynamic shape adaptation
Obviousness Reasoning
A PHOSITA would recognize that advanced material technologies naturally extend balloon catheter design, with shape-memory alloys providing predictable improvements in catheter performance and patient outcomes
Source Patent Element
Flow valve for selective fluid communication
PTD Variation
Multi-lumen catheter system with integrated sensing and perfusion monitoring capabilities
Obviousness Reasoning
Expanding catheter functionality through additional lumens represents a known design approach for medical devices, with predictable benefits in diagnostic and interventional capabilities
Source Patent Element
Vascular occlusion procedure for pre-conditioning and managing ischemia
PTD Variation
AI-driven real-time monitoring system for optimizing perfusion and minimizing vascular trauma
Obviousness Reasoning
Incorporating computational monitoring into medical device design is a predictable technological progression, leveraging known machine learning techniques to enhance existing medical intervention strategies
Source Patent Element
Low-profile occlusion catheter system
PTD Variation
Micro-robotic navigation module for precise catheter placement and real-time perfusion monitoring
Obviousness Reasoning
Enhancing catheter precision through robotic navigation represents an obvious technological improvement consistent with ongoing medical device innovation trends
Source Patent Element
Catheter with selective fluid communication
PTD Variation
Nanotechnology-enhanced occlusion balloon for targeted therapeutic agent delivery
Obviousness Reasoning
Integrating targeted drug delivery mechanisms into existing catheter technologies represents a predictable and incremental advancement in medical device design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857737 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed innovations obvious and therefore unpatentable. The published technical disclosure demonstrates that the claimed advancements represent predictable combinations of known medical device technologies, utilizing standard engineering approaches to incrementally improve vascular occlusion catheter systems.

Original Patent Information

Patent NumberUS 11,857,737
TitleSystem and method for low-profile occlusion balloon catheter
Assignee(s)PRYTIME MEDICAL DEVICES, INC.